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Signal transductiontion of epithelial tumor cells with extracellular matrix (ECM) is critical for their
migration, but also for hematogenous dissemination. Elevated expression and activity of Src family kinases
(SFKs) in colon cancer cells is often required in the disease progression. In this work, we highlighted how
focal adhesion kinase (FAK) and SFKs interacted and we analyzed how PI3K/Akt and MAPK/Erk1/2 signaling
pathways were activated in early stages of colon cancer cell adhesion. During the ﬁrst hour, integrin
engagement triggered FAK-Y397 phosphorylation and a fraction of FAK was located in lipid rafts/caveolae
domains where it interacted with Fyn. The FAK-Y861 and/or -Y925 phosphorylations led to a subsequently
FAK translocation out of lipid domains. In parallel, a PI3K/Akt pathway dependent of lipid microdomain
integrity was activated. In contrast, the MAPK/Erk1/2 signaling triggered by adhesion increased during at
least 4 h and was independent of cholesterol disturbing. Thus, FAK/Fyn interaction in lipid microdomains and
a Akt-1 activation occurred at the same time during early contact with ECM suggesting a speciﬁc signaling
dependent of lipid rafts/caveolae domains.
© 2008 Elsevier B.V. All rights reserved.1. Introduction
During cancer progression, tumor cells acquire migrating cap-
ability and effective ‘homing’ in body host environment. Cellular
adhesion and migration processes involve cell adhesion molecules
such as integrins that link components of the extracellular matrix
(ECM) with cytoskeletal proteins.
One of the major tyrosine phosphorylation activities linked to
integrin signaling is that of focal adhesion kinase (FAK). High amount
of FAK is located in specialized subcellular compartments so-called
focal adhesions. The primary function of FAK is to transmit the
adhesion signal coming from integrins to the intracellular signaling
cascade. Integrin engagement is responsible for FAK autophosphor-
ylation at Y397, activating a binding site that leads to its association
with Src family protein tyrosine kinases (SFKs). SFK association with
FAK induces other tyrosine phosphorylations of FAK. To date, ﬁve sites
have been identiﬁed, namely tyrosine 407, 576, 577, 861 and 925 [1,2].
These tyrosine phosphorylations generate high afﬁnity binding sites
for several intracellular signaling molecules and full activation of FAK.
Together with FAK, these signaling molecules recruit and activate
regulators of Erk, Jun kinase, and Rho signaling pathways, which
modulate multiple genes expression [3,4].: +33 04 91 83 56 53.
r (G. Baillat).
l rights reserved.SFKs, consisting of c-Src, Yes, Fyn, Lck, Lyn, Hck, Fgr, Blk and Yrk, are
important signaling enzymes that share considerable structural
homology and control cell growth, proliferation and migration [5].
Only c-Src, Yes, and Fyn are usually described as ‘ubiquitously’
expressed [6]. The most characteristic feature of SFKs is that their
activities are strictly regulated by two tyrosine phosphorylations.
Tyrosine 416 of c-Src is a conserved tyrosine in the kinase domain of
SFKs and its phosphorylation leads to full activation, whereas tyrosine
phosphorylation in the C-terminal region (Y527 for Src) leads to their
inactivation. The SFK signaling is achieved by phosphorylation of
speciﬁc substrates such as FAK and/or recruitment of speciﬁc pools of
SFKs within the cell.
SFKs are localized in distinct subcellular compartments, including
cholesterol-enriched microdomains [7]. These lipid microdomains are
small, heterogeneous, highly dynamic, sterols- and sphingolipids-
enriched. Two types of lipid related subdomains have been character-
ized with structural and functional differences: the lipid rafts and the
caveolae [8]. Caveolae are plasma membrane invaginations formed by
oligomerization of caveolin-1 that have been implicated in a variety of
cellular processes, including signal transduction, endocytosis, trans-
cytosis and cholesterol trafﬁcking. It has been proposed that the
function of lipid rafts is the spatial concentration of sets of proteins in
specialized membrane areas to increase the efﬁciency and the
speciﬁcity of signal transduction and to prevent cross-talk between
pathways [9].
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nated toward distant sites where they form subsequent metastases.
Detachment of tumor cells induces a focal adhesion disassembly with
mechanisms close to those observed during focal adhesion turnover.
Adhesion of these detached cells in a metastasis site has particularly
crucial effects on survival and on regulation of kinase signaling for
cells of epithelial origin. Integrin engagement with ECM promotes
assembly of several molecules, including SFKs and FAK, and initiates
focal adhesion reformation [10].
However, surprisingly, FAK and SFKs are not located in the same area
since SFKs, in contrast to FAK, are described to be largely associated to
lipid microdomains [7]. We hypothesized that FAK could interact with
SFKs in lipid rafts/caveolae domains and that this interaction triggered a
speciﬁc signaling during early attachment of cells. Thus,we studied the
time-courses and the spatial compartmentalizations of FAK/SFK
interactions and of PI3K and MAPK pathways activation in early
adhesion using SW480 cells as model of colon cancer cell.
2. Materials and methods
2.1. Reagents
Unless noted, all reagents were purchased from Sigma-Aldrich.
Rabbit polyclonal antibodies (Abs) raised against phospho (p)-Akt
(Ser-473), p-FAK (Tyr397), p-FAK (Tyr925), p-Src family (Tyr416), p-
Erk 1/2 (Thr-202/Tyr-204) and Akt-1 were purchased from Cell
Signaling. P-Src family (Tyr416) is named in reference to the
conserved sequence of activation loop in chicken c-Src. Rabbit
polyclonal Abs raised against FAK (C 20), p-FAK (Tyr861), SFKs
(named c-Src (SCR2)), c-Src (N16), Fyn, Erk1, caveolin-1 (N-20),
PI3K-P85α and mouse mAb raised against c-Yes were purchased
from Santa Cruz Biotechnology. HRP-conjugated anti-rabbit and
anti-mouse IgG secondary Abs and enhanced chemiluminescence
reagents (ECL) were from GE Healthcare. Mouse mAb raised against
HA tag was from Euromedex. Pharmacological inhibitors SU6656
and PP2 were from Calbiochem.
2.2. Cell culture and adhesion
HT29-D4 cells were cloned by limiting dilution of the HT29
parental cell line [11]. SW480 and SW620 cells were a generous gift of
Pr. M. Bracke (Gent University Hospital, Belgium). Each cell line was
routinely cultured in high glucose DMEM supplemented with 10%
fetal calf serum (FCS) at 37 °C in 5% CO2.
Cells were starved 4 h in FCS- and calcium-free MEM (SMEM)
supplemented with 0.2% BSA and then detached with 5 mM EDTA.
Suspended cells were maintained in FCS-free SMEM during 1 h to
keep cells isolated and to inactivate outside signals. Then, they were
allowed to adhere in low-density condition in six-well plates (2×105
cells/well) or 100 mm plates (106 cells) at 37 °C in FCS-free DMEM
supplemented with 0.2% fatty acid free BSA. Beforehand wells were
coated with FCS or type I collagen.
For assays with inhibitors, 20 μM PP2, 60 μM SU6656 or 100 nM
actinomycin-D was added in suspended cells and during adhesion.
For cholesterol depletion experiments, 10 mMmethyl-β-cyclodex-
trin (Met-β-CD) was incubated 1 h with suspended cells only before
adhesion. To examine the effects of cholesterol repletion, this
incubation was carried out in the presence of cholesterol (8 mg/ml).
Following either cholesterol depletion or depletion/repletion, the cells
were washed three times, and then prepared for adhesion assays as
described above.
Adhesion kinetics were performed as previously described [12].
Brieﬂy, treated or untreated cells as described above, in single cell
suspension, were added to FCS- or type I collagen-coated wells (96-
well plate, 104 cells/well) and allowed to adhere at 37 °C for
different times in the presence of inhibitors. 100% adhesion wasmeasured with the same number of cells ﬁxed by 1% glutaralde-
hyde. After several washings, attached cells were stained by 0.1%
crystal violet and lysed with 1% SDS. Absorbance was then
measured at 600 nm.
In all assays, cell viability was controlled by trypan blue exclusion.
2.3. Membrane raft preparation
Highly puriﬁed rafts were isolated by extraction with Brij 98 at
37 °C followed by Optiprep density gradient centrifugation,
essentially as previously reported [13], allowing us to speciﬁcally
analyze interactions present at physiological temperature. In brief,
∼30×106 cells were sonicated (ﬁve 5-s bursts, 5 W) in 1 ml of ice-
cold buffer A (25 mM HEPES pH 7.6, 150 mM NaCl, 1 mM EGTA,
10 mM NaF, 5 mM Na3VO4, 10 mM NaP-P, and a mixture of protease
inhibitors). The post-nuclear supernatant was recovered after
centrifugation at 800 ×g at 4 °C for 10 min, and then extracted
with buffer A containing 1% Brij 98 for 5 min at 37 °C. After dilution
with Optiprep 60% containing 5% sucrose (ﬁnal concentration:
Optiprep 43%, sucrose 3.3%, Brij 98 0.3%), lysates were chilled
down on ice for 1 h and placed in a centrifuge tube. Samples were
then overlaid with 1 ml of 30%, 2 ml of 21%, 3 ml of 20%, 2 ml of
19% and 1 ml of 0% Optiprep in buffer A. The gradients were spun at
175,000 ×g in a SW41 rotor (Beckmann Instruments) for 16 h at
4 °C. Fractions were collected from top to bottom of centrifuge tubes
and the 19% Optiprep layer was diluted 10-fold with buffer A and
concentrated by ultracentrifugation (2 h, 100,000 ×g). Resuspended
pellet was referred to as buoyant fraction or rafts/caveolae fraction.
The last 4 ml of the bottom of centrifuge tube corresponding to
layers 30% and 43% Optiprep and containing solubilized membrane
and cytosolic extract were referred to as high density fraction or
non-raft fraction. Buoyant fraction was separated from non-raft
fraction by broad layers of Optiprep 21% and 20% to completely
prevent the ﬂoating of high density molecules. Under these
conditions, known non-raft proteins like clathrin heavy chain or
Erk1/2 were totally excluded from rafts/caveolae fraction (Supple-
mentary Fig. S1).
2.4. Transfections
FAK cDNA constructs containing the HA1 triple tag were a
generous gift of Pr. Steven K. Hanks (Vanderbilt University School of
Medicine, Nashville, TN, USA). Brieﬂy, site-directed mutagenesis was
used to change codons for FAK phosphoacceptor tyrosines to
phenylalanine codons. Eukaryote expression plasmids encoding FAK
variants of the different phosphorylation sites were referred to as
wild-type- (wt-), F397Y-, F861Y- and F925Y-FAK [1,14].
Batches of 5×106 cells were used in each transfection
experiment with the Nucleofector™ (Amaxa Biosystems, Germany).
Cells were re-suspended in 100 μl Nucleofector™ solution T at
room temperature followed by addition of 5 μg of mutated or non-
mutated FAK plasmids. Programs T-20 was used for transfecting
the cells. Immediately after transfection, cells were plated in
culture medium and incubated 48 h at 37 °C in 5% CO2. Cell
viability and transfection efﬁciencies, determined with control
plasmid pmaxGFP (Amaxa Biosystems), were about 50%. Trans-
fected cells were used for adhesion experiments as described
above and HA-tagged proteins expression was speciﬁcally monitored
by Western blot.
2.5. Immunoprecipitation assay
Fraction related to 19% Optiprep layer was homogenized in a glass-
Teﬂon Potter homogenizer with 2% N-octyl β-D-glucopyranoside
(OGP) as previously published [15]. After overnight incubation with
1 μg of Ab against FAK, protein G-agarose conjugate beads were added
2325G. Baillat et al. / Biochimica et Biophysica Acta 1783 (2008) 2323–2331for 1 h at 4 °C with constant stirring. Then, beads were washed three
times with 20 mM Tris–HCl (pH 8.0), 1% OGP, 200 mM NaCl, 1 mM
EDTA, 10 mM Na3VO4, 10 mM NaP-P, 10 mM NaF and a mixture of
protease inhibitors and once with PBS. The non-raft fraction was
directly diluted in washing buffer described above and submitted to
immunoprecipitation assay as described above. In all cases, immuno-
precipitated proteins were analyzed by Western blotting.
2.6. Western blot analysis
After different adhesion times, non-adherent cells were gently
washed away and pooled with harvested adherent cells to keep the
same amount of cells. Proteins extracted and immunoprecipitated
samples were subjected to SDS-PAGE (8 or 10% acrylamide), then
electrophoretically transferred onto Hybond-C extra nitrocellulose
sheets (Amersham) and probed with the indicated primary Abs or
HRP-coupled cholera toxin B chain. Bound Abs were then detected
according to the ECL protocol. Blots densitometry was quantiﬁed with
the ImageMaster software (Amersham).
2.7. Statistical analysis
Data shown are means+/−SEM for at least three separate experi-
ments (n≥3). Statistical differences were analyzed by use of Student's t
test for paired data. A P value b0.05 was considered signiﬁcant.Fig. 1. SW480 cell adhesion kinetics. (A) SW480 cell adhesion kinetics on complex matrix-coa
pretreatment with 10mMMet-β-CD (●) versus untreated control cells (♦). Data were expres
versus untreated cells were statistically signiﬁcant (Pb0.05). Phosphorylation kinetics of F
adhesion in the absence (B, C) or in the presence of 20 μM PP2 (D, E). (B, D) Western blotting
quantiﬁed and total FAK signal was used as normalization reference to compare the differe
(grey bars), FAK-Y861 (hatched bars) and FAK-Y925 (white bars) phosphorylations between3. Results
3.1. Time-course of SW480 cell adhesion and of FAK-Y397
autophosphorylation
The totality of SW480 cells adhered on complex matrix in 4 h (Fig.
1A). At this time, cells remained round and did not spread. Flattening
and generation of protrusions were observed only after an additional
period of 4 to 6 h. Actinomycin-D, a inhibitor of transcription, did not
disturb adhesion time-course showing that protein synthesis was not
implied (data not shown). Although extracellular signalings were
drastically reduced after cell starvation and suspension, no cell death
was observed in these experiments.
Src expression and its tyrosine kinase activity appear
particularly raised in many epithelial cancers, including colon
carcinomas [6]. To clarify how SFK activity was implied in cell
adhesion, PP2 and SU6656, two speciﬁc SFK inhibitors, were
used. Both potently inhibited SW480 cell adhesion (Fig. 1A) as
well as the adhesion of SW620 and HT29D4 cells, two other human
colon cancer lines (data not shown). This inhibition was observed
on complex matrix but also on type I collagen-coated surfaces (data
not shown).
As signiﬁcance of SFK localization in lipid domains remains largely
unknown, the effect of cholesterol disruption by Met-β-CD on SW480
cell adhesion was also tested (Fig. 1A). This reagent potently inhibitedted plates were performed in the presence of 20 μM PP2 (▲), 60 μM SU 6656 (■) or after
sed as percent of adherent cells versus total cells. All differences shown between treated
AK. (B–E) Phosphorylation kinetics of FAK-Y397, -Y861 and -Y925 during SW480 cell
of cell lysates was performed with the indicated antibodies. (C, E) Band densities were
nt experiments. In bar graphs, statistically signiﬁcant differences (Pb0.05) of FAK-Y397
PP2 treated (E) and control (C) cells were indicated by (⁎).
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needed fully active SFKs and functional lipid domains. In cholesterol
depletion, as in SFK inhibition assays, no cell death was observed by
trypan blue exclusion assay.
It has been shown that integrin-mediated cell adhesion promotes
FAK-Y397 autophosphorylation and FAK/SFK interaction, leading to
FAK phosphorylation on Y861 and Y925 [1,2]. Phosphorylation of
these residues creates additional protein binding sites named proline-
rich region II (Y861 phosphorylation) and Focal Adhesion Targeting
(FAT) domain (Y925 phosphorylation).
Therefore, we determined the phosphorylation kinetics of FAK-
Y397, -Y861 and -Y925 during SW480 cell adhesion with or
without PP2 (Fig. 1B–E). In suspended cells (time 0), FAK was only
lightly phosphorylated. FAK-Y397 phosphorylation quickly
increased during adhesion, reached a plateau after 1 h and
remained maximum during at least 4 h. FAK-Y861 and -Y925
phosphorylation also increased during adhesion with roughly the
same time-course (Fig. 1B and C). FAK-Y397 autophosphorylation
time-course reﬂected that cells gradually put down on plate
surface during this ﬁrst hour inducing a quick integrins engage-
ment. However, cells did not ﬁrmly adhered at this time since 50%
of cells were removed in previous adhesion test with more drastic
washings (Fig. 1A).Fig. 2. FAK distribution in raft and non-raft compartments. (A) FAK distribution in raft and no
the absence of 20 μM PP2. Western blotting of raft and non-raft fractions was performed wit
rafts/caveolae fraction and c-Src signal was used as normalization reference. In bar graphs, st
indicated by (⁎). (C) Band density of translocated FAK was quantiﬁed and c-Src signal was use
in percentage of FAK translocated between PP2-treated and untreated cells were indicated b
complexes on FAK localization in the presence of 20 μM PP2. FAK and caveolin-1 distributio
reference to compare the different assays. Shown is a representative assay out of four expeIn the majority of colon tumor cells, Src is constitutively active and
an important SFK activity is observed in N80% of colon adenocarci-
noma [16]. This appears to be the case in suspended SW480 cells (time
0) and during adhesion (Fig. 1B). However, PP2 potently, but not
completely, inhibited SFK activity as conﬁrmed by the strong decrease
of Src-Y416 phosphorylation (Fig. 1D). During cell adhesion in the
presence of PP2, time-course of FAK-Y397 autophosphorylation did
not change drastically, whereas the increase of Y861 and Y925
phosphorylation was completely inhibited (Fig. 1D and E). Thus,
during the ﬁrst hour of adhesion of SW480 cells, integrin engagement
quickly induced FAK-Y397 autophosphorylation, independently of SFK
activity, but an additional time of 3 h was necessary to reinforce
adhesion by downstream mechanisms.
3.2. Lipid domains were enriched in FAK when SFK activity was reduced
Cholesterol disruption strongly inhibited SW480 cell adhesion
(Fig. 1A) highlighting the importance of lipid domains. In order to
assess how FAK was distributed in raft and non-raft compartments
during cell adhesion, lipid domains were extracted on the basis of
their resistance to Brij98 solubilization at 37 °C and of their
ﬂoatation in a low-density layer (Fig. 2). The well established rafts/
caveolae-associated protein caveolin-1 and GM1 ganglioside weren-raft compartments at different times during SW480 cell adhesion in the presence or in
h the indicated antibodies. (B) Band densities of FAK and p-FAK Y397 were quantiﬁed in
atistically signiﬁcant (Pb0.05) differences between PP2 treated and untreated cells were
d as normalization reference. In bar graphs, statistically signiﬁcant (Pb0.05) differences
y (⁎). (D) Effect of cholesterol depletion by 10 mMMet-β-CD or by cholesterol/Me-β-CD
n in raft and non-raft compartments was examined by Western blot. C-Src was used as
riments.
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and Erk1/2, two known non-raft proteins, were found only in the
heavier fraction Cholesterol depletion and depletion/repletion assays
conﬁrmed the correct partitioning of proteins in our puriﬁed raft
and the non-raft compartment (Supplementary Fig. S1).
Highly puriﬁed lipid domains were prepared after various time of
adhesion in thepresence or in the absence of PP2 (Fig. 2A) and of SU6656
(Supplementary Fig. S2). The amount of FAK observed in rafts/caveolae
fractionprepared fromsuspended cellswas very lowanddidnot increase
during adhesion. By contrast, a quick increase of FAK concentration was
detected in buoyant fraction during adhesion of SFK inhibitors-treated
cells, reaching a maximum upon 1 h adhesion (Fig. 2B and Supplemen-
tary Fig. S2). In parallel, the amount of FAK phosphorylated on Y397
increased in rafts/caveolae fraction suggesting the importance of
activation of SFK binding site for translocation. FAK enrichment in rafts/
caveolae fraction was also observed in SW620 and HT29D4 cells treated
by PP2 during early stages of adhesion (data not shown).
Synchronously, FAK quantity decreased in non-raft fraction during
adhesion only when cells were processedwith PP2. Blot quantiﬁcation
showed that the amount of FAK translocated from non-raft to rafts/
caveolae fractions reached 12+/−1.9% upon 1 h adhesion (Fig. 2C).
However, it is possible that this translocation was minimized because
SFK activity was not totally inhibited by PP2 as shown by a residual
Src-S416 phosphorylation.
To analyze the effect of cholesterol depletion on FAK localization,
SW480 cells in suspension were treated with Met-β-CD beforeFig. 3. FAK variant distribution in raft and non-raft compartments. (A, B) Expression of H
untransfected (none) and transfected cell lysates was performed with the indicated antibo
statistically signiﬁcant (Pb0.05) differences of FAK expression ratios between transfected v
variants in raft compartment was examined in SW480 cells after 1 h adhesion in the pres
antibodies. (D) Band densities were quantiﬁed in rafts/caveolae fraction and c-Src signal
differences of HA signal were indicated by (⁎) between the FAK variants versus wt-FAK transf
cells by F397Y- versus wt-FAK. (E) Adhesion kinetics on complex matrix-coated plates of SW
expressed as percent of adherent cells versus total cells. All differences shown between FAKadhesion in the presence of PP2 (Fig. 2D). Treatment induced a drastic
shift of FAK and c-Src from the buoyant fraction to high density fraction
conﬁrming FAK localization in cholesterol-dependent microdomains.
However, Met-β-CD did not efﬁciently delocalize caveolin-1 compared
to drastic shift of FAK and c-Src, suggesting that these two proteins
could be associated to lipid rafts rather than caveolae. To ensure that
this was a speciﬁc effect of cholesterol depletion, cells were treated
with Met-β-CD in the presence of cholesterol. The shift in the
localization of FAK, c-Src and caveolin-1 was fully reversed with
cholesterol/Me-β-CD complexes, indicating that association of these
molecules with detergent-resistant membrane microdomains is
actually cholesterol-dependent.
Altogether, these data supported the idea that, during early
adhesion of colon carcinoma cells, a fraction of FAK is blocked in
buoyant fraction when SFK activity was reduced. As FAK is not
described as located in lipid domains and has no domain allowing a
direct association, we hypothesized that FAK localization in lipid
microdomains was dependent on interactions with SFK members and
could be transient. This idea was reinforced by the parallel increase of
amount of FAK phosphorylated on Y397 in rafts/caveolae fraction.
3.3. FAK accumulation in lipid domains was controlled by
Tyr phosphorylation
To clarify whether FAK phosphorylation sites were involved in raft
localization, FAK mutants, in which tyrosine phosphorylation sitesA-tagged FAK variants in SW480 cells 48 h after transfection. (A) Western blotting of
dies. (B) FAK amounts were quantiﬁed with the ImageMaster software. In bar graph,
ersus untransfected cells were indicated by (⁎). (C, D) Distribution of HA-tagged FAK
ence or in the absence of 20 μM PP2. (C) Immunoblots were analyzed using indicated
was used as normalization reference. In bar graph, statistically signiﬁcant (Pb0.05)
ected cells without PP2 or by (⁎⁎) to compare HA signal in presence of PP2 in transfected
480 cells transfected with wt- (♦), F861Y- (■) or F925Y-FAK (▲) plasmids. Data were
mutants versus wild-type transfected cells were statistically signiﬁcant (Pb0.05, n=8).
Fig. 5. Phosphorylation levels of FAK, SFKs, Akt and Erk1/2 after 1 h of adhesion.
Disturbing action of 20 μM PP2 or of pretreatment with 10 mMMet-β-CD on FAK, SFKs,
Akt and Erk1/2 phosphorylation levels was analyzed in suspended and in 1 h adhered
cells. Western blotting of cell lysates was performed using indicated antibodies. Shown
is a representative experiment out of four individual assays.
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3). A non-mutated FAK protein (wt) was also expressed as a control.
All these proteins carried a HA tag allowing to detect only the
expression of transfected FAK. 48 h after the transfection shock,
surviving cells recovered a normal morphology. Moreover, transfected
cells with wt-FAK vector displayed the same adhesion kinetics
compared to non-transfected cells (Fig. 3E versus Fig. 1A). All mutants
were expressed at equivalent levels (Fig. 3A) and increased the FAK
amount in transfected cells of about 2.5-fold compared to non-
transfected cells (Fig. 3B).
Distribution of these FAK mutants was investigated in rafts/
caveolae domains after 1 h adhesion (Fig. 3C and D). Wt-FAK
concentration was low in untreated cells, but increased when SFK
activity was inhibited by PP2 as observed with endogenous FAK.
Importantly, almost no F397Y-FAK was detected in lipid microdo-
mains whether or not cells were treated with PP2. Thus, FAK
localization in lipid domain was controlled by FAK-Y397 phosphoryla-
tion that activates the SFK binding site.
Expressed F861Y- and F925Y-FAK were detected in buoyant
domains from untreated cells in concentration equivalent to that
observed with wt-FAK in PP2-treated cells. Moreover, PP2 treatment
had no effect on their location in buoyant fraction. Thus, FAK
delocalization out of lipid rafts/caveolae domains was controlled by
Tyr phosphorylations dependent on SFK kinase activity in the FAT and
proline-rich regions of FAK. This result was conﬁrmed by co-
localization assays of GM1 with F861Y- and F925Y-FAK mutants
(Supplementary Fig. S3).
Adhesion assays were performed with cells expressing wt-, F861Y-
or F925Y-FAK mutants (Fig. 3E). If wt-FAK had no effect on kinetics,
both FAK variants slowed down SW480 adhesion, but the effect was
less important than that obtained after treatment with PP2. This resultFig. 4. FAK interactions with c-Src, Yes and Fyn in raft and non-raft compartments. In
SW480 (A) and SW620 (B) cells, the distribution of FAK, c-Src, Yes and Fynwas tested in
raft and non-raft fractions and in immunoprecipitated samples by antibodies against
FAK of each compartments (IP FAK) in the presence or in the absence of 20 μM PP2.
Proteins were revealed with the indicated antibodies on separated immunoblots for
each SFKs tested. Western immunoblottings shown were representative of three
different assays.must be largely underestimated because only 50% of cells were
transfected and endogenous FAK level remained considerable in
transformed cells.
Altogether, these data support the idea that FAK is transiently co-
located with SFKs in rafts/caveolae domains during early adhesion
process. The quick Y397 phosphorylation induced by adhesion (Fig.
1B–E) activated the SFK binding site and subsequently caused the
partial localization of FAK in lipid microdomains (Fig. 2A). Delocaliza-
tion out of these domains was regulated by SFKs-dependent
phosphorylation of tyrosine in FAT or proline-rich regions (Fig. 3C).
In addition, disturbance in the FAK phosphorylation process induced
perturbation of early adhesion.
3.4. FAK was associated with different SFK members in raft and
non-raft domains
Widely coexpressed SFK members c-Src, Fyn and Yes are involved
in various cellular events, including proliferation, survival, adhesion
andmigration, and often act downstream of receptor tyrosine kinases.
They are absolutely required to mediate speciﬁc functions regulated
by ECM proteins and tyrosine phosphorylation of focal adhesion
proteins, including FAK.
Thus, to analyze the interactions of c-Src, Yes and Fyn with FAK
in lipid domains, co-immunoprecipitation studies were performed
using raft and non-raft fractions prepared from 1 h adhered SW480
and SW620 cells in the presence or in the absence of PP2 (Fig. 4).
The three isoforms were expressed in cells, but only c-Src and Fyn
interacted with FAK in non-raft fraction as previously described [17].
These interactions were not disturbed by PP2 treatment. In contrast,
although the three isoforms were also detected in rafts/caveolae
fraction, only Fyn was co-immunoprecipitated with FAK in buoyant
fraction of PP2-treated SW480 and SW620 cells suggesting that Fyn
is the speciﬁc partner of FAK in lipid domains during the ﬁrst hour
of adhesion.
3.5. MAPK and PI3K/Akt signalings were differently altered by Met-β-CD
In addition to its kinase activity, FAK–SFK complex has been
suggested to act as a platform to integrate multiple signaling
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PI3K/Akt pathways were both known to be activated by integrin
receptor binding to ECM in different cell types [19,20].
Actions of PP2 and Met-β-CD on phosphorylation levels of FAK,
SFKs, Akt and Erk1/2 were compared in suspended and in 1 h adhered
cells (Fig. 5). In parallel to FAK-Y397 phosphorylation, Akt-S473 and
Erk1/2-T202/Y204 were phosphorylated revealing activation of PI3K
and Erk signaling pathways. As previously observed (Fig. 1B–E), PP2
did not change FAK-Y397 phosphorylation, but totally prevented
activation of PI3K and Erk pathways. In contrast, Met-β-CD did not
change FAK-Y397 phosphorylation, but completely prevented Akt-
S473 phosphorylation without affecting Erk1/2 phosphorylation.
Thus, raft integrity was crucial for the activation of PI3K/Akt but not
of MAPK/Erk pathways during the ﬁrst hour of adhesion process.
To clarify how these two pathways were regulated during the ﬁrst
4 h of adhesion, activation kinetics of PI3K/Akt and MAPK/Erk
signalings were compared in the absence (Fig. 6A and B) or in the
presence of Met-β-CD (Fig. 6C and D). Without Met-β-CD, Akt-1
phosphorylation reached a plateau after 45 min of adhesion and then
remained maximum. In contrast, Erk1/2 phosphorylation increased
gradually during the 4 h tested.
Met-β-CD totally prevented Akt-S473 but not Erk1/2 phosphoryla-
tion (Fig. 6C and D) whereas cholesterol repletion allowed a correct
Akt1 activation (Fig. 6E and F), suggesting that lipid raft has an
important role in the regulation of PI3K/Akt signaling pathway
induced during early cell adhesion. As previously described, this
signaling can be triggered by direct targeting of PI3K regulatory
subunit p85α [21] or of Akt-1 [22] in raft microdomains. However,
Akt-1was not detected in our rafts/caveolae fraction (data not shown).
Moreover, although p85α was detected in our buoyant fraction, we
failed to highlight an increased amount of p85α upon PP2 treatment.
Thus, the increase of Akt phosphorylation observed in early time of
adhesion did not seem related to a direct targeting of p85α subunit or
of Akt-1 in lipid rafts.
Kinetics of Akt-S473 phosphorylation, revealing PI3K/Akt pathway
activation, was in strong correlation with time-course of FAK-Y397
phosphorylation that was the reﬂection of integrin engagement.
Moreover, Akt phosphorylation was SFK activity-dependent. Thus,
PI3K/Akt pathway activation must be connected to the interaction
between FAK and members of the SFKs. As this process was alsoFig. 6. Phosphorylation kinetics of Akt-S473 and Erk1/2-T202/Y204 during adhesion of un
pretreatment with 10 mMMet-β-CD and cholesterol repletion (E, F). (A, C and E)Western blo
were quantiﬁed with the ImageMaster software. Total Akt and Erk 1/2 signals were used as
statistically signiﬁcant (Pb0.05) differences between Akt-S473 (black bars) and Erk1/2-Erk1
times versus initial time were indicated by (⁎).sensitive to Met-β-CD, a cholesterol perturbing reagent, we hypothe-
size that this interaction takes place in membrane lipid microdomains
where Fyn interacts with FAK in early adhesion.
4. Discussion
Signaling pathway during cell adhesion involves a series of
sequential phosphorylation events initiated by FAK/SFK interaction.
In this work, we analyzed the activation kinetics and timeline
localization of FAK/SFK association and of PI3K and MAPK signaling
induced by early adhesion of SW480 cells.
Cell starvation and suspension in FCS- and calcium-free medium
allowed to inactivate almost completely PI3K/Akt and MAPK/Erk
signaling pathways and decreased strongly FAK phosphorylation. In
contrast, SFK activation remains unchanged. Indeed, these cells, like a
majority of colon cancer lines, are known to own high intrinsic Src
activity [23]. In these conditions, plating of these isolated cells on
complex matrix in the absence of other stimulating factors was
supposed to induce only adhesion pathways related to integrins.
Our results provide evidence that a fraction of FAK was directed
toward lipid rafts/caveolae domains during early adhesion. This
process was controlled by autophosphorylation of Y397 induced by
integrin engagement. This is in agreement with recent data suggesting
that FAK can be integrated into lipid microdomains. In adherent B16
melanoma cells, ∼10% of total FAK is detected in low-density fraction
and is associated with GM3. Rho A (50%), Ras H (95%) and c-Src (90%)
are also detected in this fraction [24,25]. In adherent pro-B cells,
stimulation by CXL chemokine ligand 12 induces FAK-Y397 phosphor-
ylation and recruitment of FAK and PI3K regulating subunit p85 into
lipid membrane domains [26]. In endothelial cells, detachment also
induced a rapid decrease in membrane order correlated with cholera
toxin subunit B-stained domains internalization. During adhesion,
membrane ﬂuidity decreases and phosphorylated FAK and caveolin-1
are located in ordered domains [27]. We excluded from discussion
some reports on FAK localization in detergent-resistant membrane
(DRM) or detergent-insoluble membrane (DIM) because the extrac-
tion procedure uses only one property of lipid domains and rafts/
caveolae fractions can be contaminated by unrelated proteins.
In parallel with FAK targeting to buoyant fraction, we observed that
FAK was continuously translocated out of lipid rafts/caveolae domainstreated SW480 cells (A, B), after pretreatment with 10 mM Met-β-CD (C, D) or after
tting of cell lysates was performed using indicated antibodies. (B, D and F) Blot densities
normalization reference to compare their respective phosphorylations. In bar graphs,
/2-T202/Y204 (white bars) phosphorylations of three independent assays at different
Fig. 7. Schematic summary andworking model of data presented in this study. Integrins engagement induces quick FAK-Y397 autophosphorylation and subsequent translocation of a
fraction of FAK in raft compartments. In lipid domains, FAK interacts only with Fyn while it interacts with c-Src and Fyn in non-raft fraction. A parallel FAK translocation from raft to
non-raft domain occurs and is FAK-Y861 and/or -Y925 phosphorylation-dependent. In parallel, a PI3K/Akt signaling is quickly activated and is dependent on lipid domain integrity. A
MAPK/Erk1/2 signaling is activated with longer kinetics and is not dependent on lipid domain integrity. Both signaling pathways contribute to adhesion process of SW480 cells.
2330 G. Baillat et al. / Biochimica et Biophysica Acta 1783 (2008) 2323–2331likely under control of Y861 and/or Y925 phosphorylation by SFKs.
Moreover, transfection by FAK variants of these two tyrosines reduced
adhesion kinetics of SW480 cells. Several other reports highlighted
the crucial role of FAK C-terminal domains in cell adhesion process.
Thus, upon activation, FAK co-localizes at focal adhesions and
structural studies have shown that the FAT domain is responsible for
this localization [4]. Interestingly, adenoviral transduction of a DNA
segment encoding the FAT domain resulted in cellular rounding and
loss of adhesion of breast cancer cells [28]. By contrast, overexpression
of FAK C-terminal fragment in MDCK cells triggers Erk phosphoryla-
tion, which in turn facilitates cells spreading and lipid raft-dependent
migration [29]. These results and our contribution suggest that FAK C-
terminal domains are important in cell adhesion and consecutive
spreading. Therefore, as FAK-Y861 and -Y925 phosphorylation activate
protein binding sites, we hypothesize that FAK translocation out of
lipid domains could be induced by interactions with other molecules
in FAT and/or proline-rich domains. To our knowledge, this is the ﬁrst
time that FAK was reported dynamically localized in lipid raft under
control of phosphorylation by SFKs.
In consideration of their dynamic properties, lipid rafts could
function as microcompartments for the preassembly of signaling
complexes integrating SFKs [30]. In Src(−/−), Yes(−/−) and Fyn(−/−)
ﬁbroblasts, expression of palmitoyl-modulated mutants of these
SFKs restores speciﬁcally FAK tyrosine phosphorylation on Y861,
highlighting the importance of the correct subcellular location of SFKs
in lipid domains [31]. Thus, in mouse ﬁbroblasts, Fyn, Src, Yes and Lyn
are detected in lipid domain, but only Fyn remain permanently
present and concentrated in lipid rafts, whereas Src is transiently
relocated to non-raft fraction during cell adhesion. In these cells, Fyn
localized in rafts is the predominant kinase for Cbp, a C-terminal Src
binding protein, which serves as a sensor of adhesion [32]. Moreover,
during cell-matrix interaction of ﬁbroblasts, Fyn but not Src is
recruited to focal contacts at early times (30 min) and its palmitoyla-
tion is required for this recruitment. Fyn and its substrate p130Cas arealso involved in the rigidity response and accelerate cell spreading
[33]. Indeed, although all SFKs are myristoylated and have the ability
to attach the cellular membrane, only Fyn is palmitoylated in its N-
terminal domain and strongly associated to rafts, suggesting that Fyn
can play a speciﬁc role in lipid domain. This is in accordance to our
present data showing that Fyn was the speciﬁc SFKs that interacted
with FAK in lipid rafts/caveolae domain during early stage of adhesion.
MAPK/Erk and PI3K/Akt signaling pathways were activated during
SW480 cell adhesion. Both activations were SFKs-dependent, but only
Akt phosphorylation was sensitive to cholesterol disturbing. Other
reports describe a role for lipid rafts in PI3K/Akt modulation. For
instance, in Vero cells stimulated by LPA, p85α is found located in lipid
rafts and cholesterol depletion speciﬁcally modulates phosphoryla-
tion of Akt-1, but not of Erk1/2 [34]. In the same way, in newly formed
oligodendrocytes, lipid raft integrity is required for PI3K activation
elicited by PDGF [35] and, in LNCaP prostate cancer cells, a
subpopulation of Akt-1 is speciﬁcally activated in lipid fractions [22].
Moreover, in cells derived from small cell lung cancer, the PI3K/Akt
signaling in response to growth factors stimulation is dependent on
lipid raft integrity in contrast to Ras activation [36].
If these reports underline the importance of lipid domains in
activation of PI3K/Akt pathway, our work shows for the ﬁrst time
that FAK in lipid raft can act as a signaling intermediate regulated
by Fyn during early adhesion process. We did not ﬁnd an increase of
p85α quantity or a Akt-1 recruitment in lipid fraction as previously
described [21,22]. However p85α was detected in buoyant fraction.
Thus, we hypothesize that Akt pathway activation probably resulted
from phosphorylations events initiated in raft microdomain by PI3K
and was implied in a positive environmental signal induced by ECM
contact [37]. Moreover, other isoforms of PI3K could be implied in
this activation.
During SW480 cell adhesion, we observed that MAPK/Erk signal-
ing required longer time than PI3K/Akt pathway to be fully activated.
Several authors reported differences in MAPK and PI3K pathways
2331G. Baillat et al. / Biochimica et Biophysica Acta 1783 (2008) 2323–2331activation during cell adhesion. During adhesion of Caco-2 cells, FAK/
Src signaling contributes to the activation of PI3K/Akt and MAPK/Erk
pathways in undifferentiated cells, but does not inﬂuence PI3K/Akt
signal in differentiated ones [38]. In suspended epithelial cells,
physical forces, such as shear and pressure, stimulate adhesion by
increasing FAK phosphorylation and subsequently by modulating
integrins binding afﬁnity. This force-activated adhesiveness involves
Src, PI3K and Akt-1 but not Erk [39], indicating that these two
pathways seems regulated by different independent processes during
cell adhesion. Particularly, the recruitment of several focal adhesion-
associated proteins and activation of MAPK/Erk need the clustering of
integrins/FAK complexes [40], suggesting that the observed duration
of Erk1/2 phosphorylation depends on the time necessary to build
these clusters and to obtain a strong adhesion.
A schematic diagram was proposed in Fig. 7 to summarize our
results and integrated the effects of inhibitory reagents. No doubt that
an exact structural and biochemical deﬁnition of how FAK acts in
concert with other molecules to reinforce adhesion and initiate
spreading will be a fascinating target of future studies.
Acknowledgements
We thank Pr S.K. Hanks (Department of Cell and Developmental
Biology, Vanderbilt University School of Medicine, Nashville, Tennes-
see, USA) for kindly providing variants FAK plasmids and Pr M. Bracke
(Department of Radiotherapy and Experimental Cancer, University
Hospital Gent, Belgium) for gift of SW480 and SW620 colon cancer
lines.
We thank Dr M. Lehmann and Dr F. Andre for their critical
comments on manuscript. Our research was supported by the
Cancéropôle Provence Alpes Côte d'Azur and Association pour la
Recherche sur le Cancer (ARC).
Appendix A. Supplementary data
Supplementary data associated with this article can be found, in
the online version, at doi:10.1016/j.bbamcr.2008.08.008.
References
[1] M.B. Calalb, T.R. Polte, S.K. Hanks, Tyrosine phosphorylation of focal adhesion
kinase at sites in the catalytic domain regulates kinase activity: a role for Src
family kinases, Mol. Cell. Biol. 15 (1995) 954–963.
[2] D.D. Schlaepfer, T. Hunter, Evidence for in vivo phosphorylation of the Grb2 SH2-
domain binding site on focal adhesion kinase by Src-family protein-tyrosine
kinases, Mol. Cell. Biol. 16 (1996) 5623–5633.
[3] D.D. Schlaepfer, S.K. Mitra, Multiple connections link FAK to cell motility and
invasion, Curr. Opin. Genet. Dev. 14 (2004) 92–101.
[4] J.T. Parsons, Focal adhesion kinase: the ﬁrst ten years, J. Cell Sci. 116 (2003)
1409–1416.
[5] R.A. Klinghoffer, C. Sachsenmaier, J.A. Cooper, P. Soriano, Src family kinases are
required for integrin but not PDGFR signal transduction, EMBO J. 18 (1999)
2459–2471.
[6] M.C. Frame, Src in cancer: deregulation and consequences for cell behaviour,
Biochim. Biophys. Acta 1602 (2002) 114–130.
[7] X. Liang, A. Nazarian, H. Erdjument-Bromage, W. Bornmann, P. Tempst, M.D. Resh,
Heterogeneous fatty acylation of Src family kinases with polyunsaturated fatty
acids regulates raft localization and signal transduction, J. Biol. Chem. 276 (2001)
30987–30994.
[8] F. Galbiati, B. Razani, M.P. Lisanti, Emerging themes in lipid rafts and caveolae, Cell
106 (2001) 403–411.
[9] A. Kusumi, K. Suzuki, Toward understanding the dynamics of membrane-raft-
based molecular interactions, Biochim. Biophys. Acta 1746 (2005) 234–251.
[10] S.K. Mitra, D.D. Schlaepfer, Integrin-regulated FAK-Src signaling in normal and
cancer cells, Curr. Opin. Cell Biol. 18 (2006) 516–523.
[11] J. Fantini, B. Abadie, A. Tirard, L. Remy, J.P. Ripert, A. el Battari, J. Marvaldi,
Spontaneous and induced dome formation by two clonal cell populations derived
from a human adenocarcinoma cell line, HT29, J. Cell Sci. 83 (1986) 235–249.
[12] A. Kadi, V. Pichard, M. Lehmann, C. Briand, D. Braguer, J. Marvaldi, J.B. Rognoni, J.
Luis, Effect of microtubule disruption on cell adhesion and spreading, Biochem.
Biophys. Res. Commun. 246 (1998) 690–695.
[13] M. Remacle-Bonnet, F. Garrouste, G. Baillat, F. Andre, J. Marvaldi, G. Pommier,
Membrane rafts segregate pro- from anti-apoptotic insulin-like growth factor-Ireceptor signaling in colon carcinoma cells stimulated by members of the tumor
necrosis factor superfamily, Am. J. Pathol. 167 (2005) 761–773.
[14] M.B. Calalb, X. Zhang, T.R. Polte, S.K. Hanks, Focal adhesion kinase tyrosine-861 is a
major site of phosphorylation by Src, Biochem. Biophys. Res. Commun. 228 (1996)
662–668.
[15] P. Munoz, M.C. Navarro, E.J. Pavon, J. Salmeron, F. Malavasi, J. Sancho, M. Zubiaur,
CD38 signaling in T cells is initiated within a subset of membrane rafts containing
Lck and the CD3-{zeta} subunit of the T cell antigen receptor, J. Biol. Chem. 278
(2003) 50791–50802.
[16] M.S. Talamonti, M.S. Roh, S.A. Curley, G.E. Gallick, Increase in activity and level of
pp60c-src in progressive stages of human colorectal cancer, Clin. Invest. 91 (1993)
53–60.
[17] B.S. Cobb, M.D. Schaller, T.H. Leu, J.T. Parsons, Stable association of pp60src and
pp59fyn with the focal adhesion-associated protein tyrosine kinase, pp125FAK,
Mol. Cell. Biol. 14 (1994) 147–155.
[18] D.J. Webb, K. Donais, L.A. Whitmore, S.M. Thomas, C.E. Turner, J.T. Parsons, A.F.
Horwitz, FAK-Src signalling through paxillin, ERK and MLCK regulates adhesion
disassembly, Nat. Cell Biol. 6 (2004) 154–161.
[19] D.D. Schlaepfer, T. Hunter, Focal adhesion kinase overexpression enhances Ras-
dependent integrin signaling to ERK2/mitogen-activated protein kinase through
interactions with and activation of c-Src, J. Biol. Chem. 272 (1997) 13189–13195.
[20] D.G. Stupack, D.A. Cheresh, Get a ligand, get a life: integrins, signaling and cell
survival, J. Cell Sci. 115 (2002) 3729–3738.
[21] H.C. Chen, P.A. Appeddu, H. Isoda, J.L. Guan, Phosphorylation of tyrosine 397 in
focal adhesion kinase is required for binding phosphatidylinositol 3-kinase, J. Biol.
Chem. 271 (1996) 26329–26334.
[22] R.M. Adam, N.K. Mukhopadhyay, J. Kim, D. Di Vizio, B. Cinar, K. Boucher, K.R.
Solomon, M.R. Freeman, Cholesterol sensitivity of endogenous and myristoylated
Akt, Cancer Res. 67 (2007) 6238–6246.
[23] T.C. Windham, N.U. Parikh, D.R. Siwak, J.M. Summy, D.J. McConkey, A.J. Kraker, G.E.
Gallick, Src activation regulates anoikis in human colon tumor cell lines, Oncogene
21 (2002) 7797–7807.
[24] S.I. Hakomori, Cell adhesion/recognition and signal transduction through glyco-
sphingolipid microdomain, Glycoconj. J. 17 (2000) 143–151.
[25] K. Iwabuchi, S. Yamamura, A. Prinetti, K. Handa, S.I. Hakomori, GM3-enriched
Microdomain involved in cell adhesion and signal transduction through
carbohydrate-carbohydrate interaction in mouse melanoma B16 cells, J. Biol.
Chem. 273 (1998) 9130–9138.
[26] Y. Le, M. Honczarenko, A.M. Glodek, D.K. Ho, L.E. Silberstein, CXC chemokine
ligand 12-induced focal adhesion kinase activation and segregation into
membrane domains is modulated by regulator of G protein signaling 1 in Pro-B
cells, J. Immunol. 174 (2005) 2582–2590.
[27] K. Gaus, S. Le Lay, N. Balasubramanian, M.A. Schwartz, Integrin-mediated adhesion
regulates membrane order, J. Cell Biol. 174 (2006) 725–734.
[28] L.H. Xu, X. Yang, R.J. Craven, W.G. Cance, The COOH-terminal domain of the focal
adhesion kinase induces loss of adhesion and cell death in human tumor cells, Cell
Growth Differ. 9 (1998) 999–1005.
[29] W.C. Wei, Y.C. Hsu, W.T. Chiu, C.Z. Wang, C.M. Wu, Y.K. Wang, M.R. Shen, M.J. Tang,
Low substratum rigidity of collagen gel promotes ERK phosphorylation via lipid
raft to augment cell migration, J. Cell. Biochem. 103 (2007) 1111–1124.
[30] P.F. Lenne, L. Wawrezinieck, F. Conchonaud, O. Wurtz, A. Boned, X.J. Guo, H.
Rigneault, H.T. He, D. Marguet, Dynamic molecular conﬁnement in the plasma
membrane by microdomains and the cytoskeleton meshwork, EMBO J. 25 (2006)
3245–3256.
[31] E. Sandilands, V.G. Brunton, M.C. Frame, The membrane targeting and spatial
activation of Src, Yes and Fyn is inﬂuenced by palmitoylation and distinct RhoB/
RhoD endosome requirements, J. Cell Sci. 120 (2007) 2555–2564.
[32] T. Shima, S. Nada, M. Okada, Transmembrane phosphoprotein Cbp senses cell
adhesion signaling mediated by Src family kinase in lipid rafts, Proc. Natl. Acad.
Sci. 100 (2003) 14897–14902.
[33] A. Kostic, M.P. Sheetz, Fibronectin rigidity response through Fyn and p130Cas
recruitment to the leading edge, Mol. Biol. Cell. 17 (2006) 2684–2695.
[34] C. Peres, A. Yart, B. Perret, J.P. Salles, P. Raynal, Modulation of phosphoinositide 3-
kinase activation by cholesterol level suggests a novel positive role for lipid rafts in
lysophosphatidic acid signalling, FEBS Lett. 534 (2003) 164–168.
[35] L. Decker, C. Ffrench-Constant, Lipid rafts and integrin activation regulate
oligodendrocyte survival, J. Neurosci. 24 (2004) 3816–3825.
[36] A. Arcaro, M. Aubert, M.E. Espinosa del Hierro, U.K. Khanzada, S. Angelidou, T.D.
Tetley, A.G. Bittermann, M.C. Frame, M.J. Seckl, Critical role for lipid raft-
associated Src kinases in activation of PI3K-Akt signalling, Cell Signal. 19 (2007)
1081–1092.
[37] E.J. Müller, L. Williamson, C. Kolly, M.M. Suter, Outside-in signaling through
integrins and cadherins: a central mechanism to control epidermal growth and
differentiation? J. Invest. Dermatol. 128 (2008) 501–516.
[38] V. Bouchard, M.J. Demers, S. Thibodeau, V. Laquerre, N. Fujita, T. Tsuruo, J.F.
Beaulieu, R. Gauthier, A. Vézina, L. Villeneuve, P.H. Vachon, Fak/Src signaling in
human intestinal epithelial cell survival and anoikis: differentiation state-speciﬁc
uncoupling with the PI3-K/Akt-1 and MEK/Erk pathways, J. Cell. Physiol. 212
(2007) 717–728.
[39] M.D. Basson, An intracellular signal pathway that regulates cancer cell adhesion in
response to extracellular forces, Cancer Res. 68 (2008) 2–4.
[40] B.Z. Katz, S. Miyamoto, H. Teramoto, M. Zohar, D. Krylov, C. Vinson, J.S. Gutkind, K.
M. Yamada, Direct transmembrane clustering and cytoplasmic dimerization of
focal adhesion kinase initiates its tyrosine phosphorylation, Biochim. Biophys.
Acta 1592 (2002) 141–152.
